Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Pflugers Arch
2012 Mar 01;4633:405-18. doi: 10.1007/s00424-011-1035-1.
Show Gene links
Show Anatomy links
Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.
Cui G
,
Song B
,
Turki HW
,
McCarty NA
.
???displayArticle.abstract???
Previous studies suggested that four transmembrane domains 5, 6, 11, 12 make the greatest contribution to forming the pore of the CFTR chloride channel. We used excised, inside-out patches from oocytes expressing CFTR with alanine-scanning mutagenesis in amino acids in TM6 and TM12 to probe CFTR pore structure with four blockers: glibenclamide (Glyb), glipizide (Glip), tolbutamide (Tolb), and Meglitinide. Glyb and Glip blocked wildtype (WT)-CFTR in a voltage-, time-, and concentration-dependent manner. At V (M) = -120 mV with symmetrical 150 mM Cl(-) solution, fractional block of WT-CFTR by 50 μM Glyb and 200 μM Glip was 0.64 ± 0.03 (n = 7) and 0.48 ± 0.02 (n = 7), respectively. The major effects on block by Glyb and Glip were found with mutations at F337, S341, I344, M348, and V350 of TM6. Under similar conditions, fractional block of WT-CFTR by 300 μM Tolb was 0.40 ± 0.04. Unlike Glyb, Glip, and Meglitinide, block by Tolb lacked time-dependence (n = 7). We then tested the effects of alanine mutations in TM12 on block by Glyb and Glip; the major effects were found at N1138, T1142, V1147, N1148, S1149, S1150, I1151, and D1152. From these experiments, we infer that amino acids F337, S341, I344, M348, and V350 of TM6 face the pore when the channel is in the open state, while the amino acids of TM12 make less important contributions to pore function. These data also suggest that the region between F337 and S341 forms the narrow part of the CFTR pore.
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995, Pubmed
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995,
Pubmed
Alexander,
Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore.
2009,
Pubmed
,
Xenbase
Aller,
Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.
2009,
Pubmed
Amalric,
Behavioral effects of modulators of ATP-sensitive K+ channels in the rat dorsal pallidum.
1992,
Pubmed
Anderson,
Nucleoside triphosphates are required to open the CFTR chloride channel.
1991,
Pubmed
Bai,
Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation.
2010,
Pubmed
Baukrowitz,
Coupling of CFTR Cl- channel gating to an ATP hydrolysis cycle.
1994,
Pubmed
Cai,
Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents.
1999,
Pubmed
Cheung,
Locating the anion-selectivity filter of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel.
1997,
Pubmed
Chien,
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.
2010,
Pubmed
Cotten,
Cystic fibrosis-associated mutations at arginine 347 alter the pore architecture of CFTR. Evidence for disruption of a salt bridge.
1999,
Pubmed
Cui,
Mutations at arginine 352 alter the pore architecture of CFTR.
2008,
Pubmed
,
Xenbase
Dörschner,
Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
1999,
Pubmed
Fatehi,
On the origin of asymmetric interactions between permeant anions and the cystic fibrosis transmembrane conductance regulator chloride channel pore.
2007,
Pubmed
Fuller,
The block of CFTR by scorpion venom is state-dependent.
2005,
Pubmed
,
Xenbase
Fuller,
Inhibition of CFTR channels by a peptide toxin of scorpion venom.
2004,
Pubmed
,
Xenbase
Gong,
Molecular determinants and role of an anion binding site in the external mouth of the CFTR chloride channel pore.
2003,
Pubmed
Gong,
Mutation-induced blocker permeability and multiion block of the CFTR chloride channel pore.
2003,
Pubmed
Guinamard,
Arg352 is a major determinant of charge selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel.
1999,
Pubmed
Gupta,
Point mutations in the pore region directly or indirectly affect glibenclamide block of the CFTR chloride channel.
2002,
Pubmed
Hwang,
Regulation of the gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis.
1994,
Pubmed
Linsdell,
Disulphonic stilbene block of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a mammalian cell line and its regulation by a critical pore residue.
1996,
Pubmed
Linsdell,
Location of a common inhibitor binding site in the cytoplasmic vestibule of the cystic fibrosis transmembrane conductance regulator chloride channel pore.
2005,
Pubmed
Linsdell,
Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore.
2000,
Pubmed
Linsdell,
Flickery block of single CFTR chloride channels by intracellular anions and osmolytes.
1996,
Pubmed
McCarty,
Identification of a region of strong discrimination in the pore of CFTR.
2001,
Pubmed
,
Xenbase
McCarty,
Permeation through the CFTR chloride channel.
2000,
Pubmed
McDonough,
Novel pore-lining residues in CFTR that govern permeation and open-channel block.
1994,
Pubmed
McNicholas,
Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator.
1996,
Pubmed
,
Xenbase
Mornon,
Molecular models of the open and closed states of the whole human CFTR protein.
2009,
Pubmed
Mornon,
Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces.
2008,
Pubmed
Muanprasat,
Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy.
2004,
Pubmed
Raeburn,
RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine.
1991,
Pubmed
Reyes,
Structure of the ABC transporter MsbA in complex with ADP.vanadate and lipopolysaccharide.
2005,
Pubmed
Riordan,
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
1989,
Pubmed
Schultz,
Glibenclamide blockade of CFTR chloride channels.
1996,
Pubmed
Serohijos,
Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.
2008,
Pubmed
Sheppard,
Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a murine cell line.
1997,
Pubmed
Sheppard,
Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents.
1992,
Pubmed
Sheppard,
CFTR channel pharmacology: novel pore blockers identified by high-throughput screening.
2004,
Pubmed
Smith,
CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction.
2001,
Pubmed
,
Xenbase
Tabcharani,
Halide permeation in wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels.
1997,
Pubmed
Tabcharani,
Multi-ion pore behaviour in the CFTR chloride channel.
1993,
Pubmed
Venglarik,
Tolbutamide causes open channel blockade of cystic fibrosis transmembrane conductance regulator Cl- channels.
1996,
Pubmed
Zhang,
Direct comparison of NPPB and DPC as probes of CFTR expressed in Xenopus oocytes.
2000,
Pubmed
,
Xenbase
Zhang,
Interaction between permeation and gating in a putative pore domain mutant in the cystic fibrosis transmembrane conductance regulator.
2000,
Pubmed
,
Xenbase
Zhang,
Steady-state interactions of glibenclamide with CFTR: evidence for multiple sites in the pore.
2004,
Pubmed
,
Xenbase
Zhang,
Voltage-sensitive gating induced by a mutation in the fifth transmembrane domain of CFTR.
2002,
Pubmed
,
Xenbase
Zhang,
Determination of the functional unit of the cystic fibrosis transmembrane conductance regulator chloride channel. One polypeptide forms one pore.
2005,
Pubmed
Zhang,
Time-dependent interactions of glibenclamide with CFTR: kinetically complex block of macroscopic currents.
2004,
Pubmed
,
Xenbase
Zhou,
Direct and indirect effects of mutations at the outer mouth of the cystic fibrosis transmembrane conductance regulator chloride channel pore.
2007,
Pubmed
Zhou,
Probing an open CFTR pore with organic anion blockers.
2002,
Pubmed
